← Oncology Approval Tracker

FDA DECISION ·

Keytruda

pembrolizumab · Merck Sharp & Dohme

Traditional approvalTraditional conversionClassical Hodgkin lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with relapsed or refractory classical Hodgkin lymphoma and children with refractory disease or relapse after at least two treatment lines.

LAMPGEN ANALYSIS

Why it matters

Converted the accelerated indication to regular approval while widening the adult population.

What research teams should watch

Apply age-specific rules for prior therapy and capture transplant history in eligibility checks.

PRIMARY RECORDS

Sources